ARCADIS NV (ARCAD.AS)

NL0006237562 - Common Stock

58.95  +0.5 (+0.86%)

Fundamental Rating

4

Taking everything into account, ARCAD scores 4 out of 10 in our fundamental rating. ARCAD was compared to 29 industry peers in the Professional Services industry. ARCAD has an average financial health and profitability rating. ARCAD does not seem to be growing, but still is valued expensively.



6

1. Profitability

1.1 Basic Checks

In the past year ARCAD was profitable.
ARCAD had a positive operating cash flow in the past year.
In the past 5 years ARCAD has always been profitable.
Each year in the past 5 years ARCAD had a positive operating cash flow.

1.2 Ratios

The Return On Assets of ARCAD (5.40%) is better than 60.71% of its industry peers.
The Return On Equity of ARCAD (18.46%) is better than 67.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.23%, ARCAD is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ARCAD is in line with the industry average of 10.91%.
The 3 year average ROIC (9.02%) for ARCAD is below the current ROIC(9.23%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.4%
ROE 18.46%
ROIC 9.23%
ROA(3y)4.6%
ROA(5y)2.98%
ROE(3y)14.89%
ROE(5y)9.62%
ROIC(3y)9.02%
ROIC(5y)8.59%

1.3 Margins

ARCAD has a Profit Margin (5.48%) which is in line with its industry peers.
ARCAD's Profit Margin has improved in the last couple of years.
ARCAD's Operating Margin of 8.49% is fine compared to the rest of the industry. ARCAD outperforms 64.29% of its industry peers.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.49%
PM (TTM) 5.48%
GM N/A
OM growth 3Y0.26%
OM growth 5Y7.36%
PM growth 3Y77.81%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARCAD is creating some value.
The number of shares outstanding for ARCAD has been increased compared to 1 year ago.
ARCAD has more shares outstanding than it did 5 years ago.
ARCAD has a better debt/assets ratio than last year.

2.2 Solvency

ARCAD has an Altman-Z score of 2.87. This is not the best score and indicates that ARCAD is in the grey zone with still only limited risk for bankruptcy at the moment.
ARCAD's Altman-Z score of 2.87 is in line compared to the rest of the industry. ARCAD outperforms 57.14% of its industry peers.
ARCAD has a debt to FCF ratio of 4.06. This is a neutral value as ARCAD would need 4.06 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.06, ARCAD is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
A Debt/Equity ratio of 1.06 is on the high side and indicates that ARCAD has dependencies on debt financing.
The Debt to Equity ratio of ARCAD (1.06) is worse than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 4.06
Altman-Z 2.87
ROIC/WACC1.45
WACC6.35%

2.3 Liquidity

ARCAD has a Current Ratio of 1.31. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.31, ARCAD is doing good in the industry, outperforming 60.71% of the companies in the same industry.
A Quick Ratio of 1.31 indicates that ARCAD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.31, ARCAD is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31

1

3. Growth

3.1 Past

ARCAD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.36%.
ARCAD shows a small growth in Revenue. In the last year, the Revenue has grown by 0.76%.
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.22%

3.2 Future

Based on estimates for the next years, ARCAD will show a decrease in Earnings Per Share. The EPS will decrease by -5.28% on average per year.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 38.28 indicates a quite expensive valuation of ARCAD.
Based on the Price/Earnings ratio, ARCAD is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
ARCAD is valuated rather expensively when we compare the Price/Earnings ratio to 27.55, which is the current average of the S&P500 Index.
ARCAD is valuated quite expensively with a Price/Forward Earnings ratio of 34.30.
Based on the Price/Forward Earnings ratio, ARCAD is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.00, ARCAD is valued a bit more expensive.
Industry RankSector Rank
PE 38.28
Fwd PE 34.3

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARCAD is on the same level as its industry peers.
ARCAD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.85
EV/EBITDA 12.75

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)3.94
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

4

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 1.44%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, ARCAD has a dividend in line with its industry peers.
ARCAD's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

The dividend of ARCAD is nicely growing with an annual growth rate of 35.08%!
Dividend Growth(5Y)35.08%
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

ARCAD pays out 36.19% of its income as dividend. This is a sustainable payout ratio.
DP36.19%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

ARCADIS NV

AMS:ARCAD (12/24/2024, 7:00:00 PM)

58.95

+0.5 (+0.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-31 2024-10-31
Earnings (Next)02-13 2025-02-13/amc
Inst Owners54.51%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap5.33B
Analysts83.16
Price Target74.26 (25.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Dividend Growth(5Y)35.08%
DP36.19%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.21%
Min Revenue beat(2)-30.71%
Max Revenue beat(2)-5.71%
Revenue beat(4)0
Avg Revenue beat(4)-13.91%
Min Revenue beat(4)-30.71%
Max Revenue beat(4)-4.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.97%
PT rev (3m)10.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.32%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-47.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 38.28
Fwd PE 34.3
P/S 1.39
P/FCF 16.85
P/OCF 14.9
P/B 4.69
P/tB N/A
EV/EBITDA 12.75
EPS(TTM)1.54
EY2.61%
EPS(NY)1.72
Fwd EY2.92%
FCF(TTM)3.5
FCFY5.93%
OCF(TTM)3.96
OCFY6.71%
SpS42.38
BVpS12.57
TBVpS-4.1
PEG (NY)3.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 18.46%
ROCE 13.42%
ROIC 9.23%
ROICexc 10.31%
ROICexgc 32.19%
OM 8.49%
PM (TTM) 5.48%
GM N/A
FCFM 8.25%
ROA(3y)4.6%
ROA(5y)2.98%
ROE(3y)14.89%
ROE(5y)9.62%
ROIC(3y)9.02%
ROIC(5y)8.59%
ROICexc(3y)10.69%
ROICexc(5y)10.89%
ROICexgc(3y)41.57%
ROICexgc(5y)54.2%
ROCE(3y)12.89%
ROCE(5y)12.26%
ROICexcg growth 3Y-0.78%
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.42%
ROICexc growth 5Y2.01%
OM growth 3Y0.26%
OM growth 5Y7.36%
PM growth 3Y77.81%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 4.06
Debt/EBITDA 2.43
Cap/Depr 24.49%
Cap/Sales 1.08%
Interest Coverage 4.46
Cash Conversion 72.32%
Profit Quality 150.68%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 2.87
F-Score7
WACC6.35%
ROIC/WACC1.45
Cap/Depr(3y)29.2%
Cap/Depr(5y)28.45%
Cap/Sales(3y)1.26%
Cap/Sales(5y)1.33%
Profit Quality(3y)176.19%
Profit Quality(5y)808.81%
High Growth Momentum
Growth
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.22%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y23.64%
EBIT growth 3Y14.96%
EBIT growth 5Y17.06%
EBIT Next Year67.61%
EBIT Next 3Y28.02%
EBIT Next 5YN/A
FCF growth 1Y26.22%
FCF growth 3Y-12.76%
FCF growth 5Y13.02%
OCF growth 1Y25.5%
OCF growth 3Y-10.39%
OCF growth 5Y7.59%